Safety and Efficacy of Subcutaneous Cardioverter Defibrillator in Patients at High Risk of Sudden Cardiac Death ― Primary Japanese Experience ―
-
- Sasaki Shingo
- Department of Advanced Management of Cardiac Arrhythmias, Hirosaki University Graduate School of Medicine
-
- Tomita Hirofumi
- Department of Cardiology, Hirosaki University Graduate School of Medicine
-
- Tsurugi Takuo
- Advanced Arrhythmia Therapeutic Branch, Division of Cardiology, Saiseikai Kumamoto Hospital Cardiovascular Center
-
- Ishida Yuji
- Department of Cardiology, Hirosaki University Graduate School of Medicine
-
- Shoji Yoshihiro
- Department of Cardiology, Hirosaki University Graduate School of Medicine
-
- Nishizaki Kimitaka
- Department of Cardiology, Hirosaki University Graduate School of Medicine
-
- Kinjo Takahiko
- Department of Cardiology, Hirosaki University Graduate School of Medicine
-
- Endo Tomohide
- Department of Cardiology, Hirosaki University Graduate School of Medicine
-
- Nishizaki Fumie
- Department of Cardiology, Hirosaki University Graduate School of Medicine
-
- Hanada Kenji
- Department of Cardiology, Hirosaki University Graduate School of Medicine
-
- Sasaki Kenichi
- Department of Cardiology, Hirosaki University Graduate School of Medicine
-
- Horiuchi Daisuke
- Department of Advanced Management of Cardiac Arrhythmias, Hirosaki University Graduate School of Medicine
-
- Kimura Masaomi
- Department of Cardiology, Hirosaki University Graduate School of Medicine
-
- Higuma Takumi
- Department of Cardiology, Hirosaki University Graduate School of Medicine
-
- Okamatsu Hideharu
- Advanced Arrhythmia Therapeutic Branch, Division of Cardiology, Saiseikai Kumamoto Hospital Cardiovascular Center
-
- Tanaka Yasuaki
- Advanced Arrhythmia Therapeutic Branch, Division of Cardiology, Saiseikai Kumamoto Hospital Cardiovascular Center
-
- Koyama Junjiroh
- Advanced Arrhythmia Therapeutic Branch, Division of Cardiology, Saiseikai Kumamoto Hospital Cardiovascular Center
-
- Okumura Ken
- Advanced Arrhythmia Therapeutic Branch, Division of Cardiology, Saiseikai Kumamoto Hospital Cardiovascular Center
この論文をさがす
抄録
<p>Background:The entirely subcutaneous implantable cardioverter defibrillator (S-ICD) was introduced as a new alternative to conventional transvenous ICD (TV-ICD) in Japan in February 2016, but its safety and efficacy are unclear.</p><p>Methods and Results:A total of 60 patients (48 men, median age, 60 years; IQR, 44–67 years; primary prevention, n=24) underwent S-ICD implantation between February 2016 and August 2017. The device pocket was formed in the intermuscular space between the serratus anterior muscle and the latissimus dorsi muscle, and the parasternal S-ICD lead was placed according to pre-implant screening. Defibrillation test was performed in 56 patients (93%). Ventricular fibrillation (VF) was induced in 55 patients and terminated by a single 65-J shock in all patients. The median time to shock therapy was 13.4 s (IQR, 12.1–14.9 s) and the median post-shock impedance of the S-ICD lead was 64 Ω (IQR, 58–77 Ω). There were no operation-related complications or subsequent infectious complications. During follow-up (median, 275 days; IQR, 107–421 days), 1 patient (1.7%) had appropriate shock for VF with successful termination, whereas 5 patients (8.3%) had inappropriate shock due to oversensing of myopotential (n=3) or T-wave (n=1), and detection of supraventricular tachycardia (n=1).</p><p>Conclusions:S-ICD is a safe and effective alternative to conventional TV-ICD. The long-term safety and efficacy of the S-ICD need further investigation.</p>
収録刊行物
-
- Circulation Journal
-
Circulation Journal 82 (6), 1546-1551, 2018-05-25
一般社団法人 日本循環器学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390282763010290560
-
- NII論文ID
- 130006744337
-
- NII書誌ID
- AA11591968
-
- ISSN
- 13474820
- 13469843
-
- NDL書誌ID
- 029008685
-
- PubMed
- 29643282
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
- KAKEN
-
- 抄録ライセンスフラグ
- 使用不可